NCT00779051 is a NA clinical trial of Zolpidem 10mg tablets in Healthy, sponsored by Ranbaxy Laboratories Limited.

Who is sponsoring NCT00779051?

NCT00779051 is sponsored by Ranbaxy Laboratories Limited.

What drugs are being tested in NCT00779051?

Interventions in NCT00779051: Zolpidem 10mg tablets.

Is NCT00779051 still recruiting?

NCT00779051 is currently completed. Last updated 23 October 2008.

Last reviewed 2008-10-23 · How we verify

NCT00779051

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

An Open Label, Relative Bioavailability Study of 10 mg Zolpidem Tablet Under Fasting Conditions

Completed NA Last updated 23 October 2008

What this trial tests

NA trial testing Zolpidem 10mg tablets in Healthy in 36 participants. Completed in 1 October 2005.

Timeline

1 August 2005

Primary endpoint
1 September 2005

1 October 2005

Quick facts

Lead sponsor	Ranbaxy Laboratories Limited
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Enrollment	36
Start date	1 August 2005
Primary completion	1 September 2005
Estimated completion	1 October 2005
Sites	1 location across United States

Drugs / interventions tested

Zolpidem 10mg tablets — full drug profile →

Conditions studied

Healthy — all drugs for Healthy →

Sponsor

Ranbaxy Laboratories Limited — full company profile →

Who can join

18 and older, any sex, with Healthy. Healthy volunteers can join.

What's being measured

Primary outcomes are the specific endpoints the trial is designed to prove or disprove.

Bioequivalence

Sponsor's own description

The study compared the relative bioavailability (rate and extent of absorption) of 10 mg Zolpidem tablets by Ohm Laboratories Inc. with that of 10 mg Ambien® tablets distributed by Sanofi-Synthelabo, Inc. following single oral dose (1x10 mg tablet) in healthy adult volunteers administered under fasting condition

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Healthy

Currently open trials in the same condition.

NCT06707207 — Predicting Future Errors During Skill Performance · recruiting
NCT07169630 — PET Imaging of Phosphodiesterase-4 (PDE4) in Volunteers With Alzheimer Disease (AD) or Mild Cognitive Impairment (MCI) · Phase 1 · recruiting
NCT07499414 — The Effects of the Bile Acid Supplement, 7-keto Lithocholic Acid, on Human Gut Microbiota and Risk Factors for Disease. · NA · recruiting
NCT07496697 — Effects of Electroacupuncture at NP82 and SP15 on Bowel Motility in Healthy Subjects · NA · recruiting
NCT06431932 — Pilot Trial of Fisetin in Healthy Volunteers and Older Patients With Multimorbidity · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00779051 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Ranbaxy Laboratories Limited
Last refreshed: 23 October 2008

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00779051.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing